Walsh M, Stevens F C
Biochemistry. 1978 Sep 19;17(19):3924-8.
Methionine residues have been implicated in the activation of cyclic nucleotide phosphodiesterase by the Ca2+-dependent protein modulator [Walsh, M., & Stevens, F.C. (1977) Biochemistry 16,2742-2749]. Treatment of the modulator with N-chlorosuccinimide in the presence of Ca2+ resulted in selective oxidation of methionine residues at positions 71,72, 76, and, possibly, 109 in the modulator sequence. These residues lie on the surface of the molecule exposed to solvent. This modification has several effects on the modulator protein: (1) the Ca2+-binding properties of the oxidized modulator are changed with apparent loss of high-affinity binding sites, (2) the oxidized protein no longer interacts with phosphodiesterase, and (3) troponin C like activities, viz., Ca2+-dependent change in mobility on urea-polyacrylamide gel electrophoresis and formation of a urea-stable complex with troponin I, are lost upon oxidation of the modulator. The phosphodiesterase binding domain of the modulator protein appears to be located between the second and third Ca2+-binding loops, a region of the molecule known from previous partial proteolysis studies [Walsh, M., Stevens, F.C., Kuznicki, J., & Drabikowski, W.(1977), J. Biol. Chem. 252, 7440-7443] to be exposed in the presence of Ca2+.
甲硫氨酸残基已被认为与钙离子依赖性蛋白调节剂激活环核苷酸磷酸二酯酶有关[沃尔什,M.,& 史蒂文斯,F.C.(1977年)《生物化学》16,2742 - 2749]。在钙离子存在下用N - 氯代琥珀酰亚胺处理该调节剂,导致调节剂序列中第71、72、76位以及可能的第109位的甲硫氨酸残基发生选择性氧化。这些残基位于分子暴露于溶剂的表面。这种修饰对调节剂蛋白有多种影响:(1)氧化后的调节剂的钙离子结合特性发生改变,高亲和力结合位点明显丧失;(2)氧化后的蛋白不再与磷酸二酯酶相互作用;(3)调节剂氧化后,肌钙蛋白C样活性,即尿素 - 聚丙烯酰胺凝胶电泳上钙离子依赖性迁移变化以及与肌钙蛋白I形成尿素稳定复合物的活性丧失。调节剂蛋白的磷酸二酯酶结合结构域似乎位于第二个和第三个钙离子结合环之间,从先前的部分蛋白酶解研究[沃尔什,M.,史蒂文斯,F.C.,库兹尼基,J.,& 德拉比科夫斯基,W.(1977年),《生物化学杂志》第252卷,7440 - 7443]可知,该分子区域在钙离子存在时会暴露出来。